GO:0098920Ontology (GO BP)GO biological process · ~5 member genes
Q-omics provides the Retrograde trans-synaptic signaling by lipid (GO:0098920) pathway profile, scoring each patient from the combined activity of its roughly 5 member genes. Pathway activity is associated with patient survival in 22 of 34 cancer types, with the highest sampling consensus in LIHC. Among the 18 cancer types available for tumor–normal comparison, the pathway is differentially active in 10, with the highest sampling consensus in COAD. Additionally, pathway RNA activity shows 33,011 significant cross-omics associations, again with the highest sampling consensus in STAD. Together, these results highlight LIHC, COAD, and STAD as cancer lineages where the pathway shows reproducible signals across outcome, tissue activity, and molecular association analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns. Pathway-against-pathway and pathway-against-mutation comparisons are not available for ontology entities.
Survival associations
This table summarizes Retrograde trans-synaptic signaling by lipid survival associations by molecular data type. RNA-level pathway activity shows survival associations in the most cancer types (22). The rightmost column indicates the cancer type with the highest sampling consensus for each layer.
This table ranks reproducible pathway activity–survival associations across cancer types. High Retrograde trans-synaptic signaling by lipid activity shows favorable associations in PRAD, but unfavorable associations in LIHC, BLCA, SKCM, COAD and CHOL. In the LIHC Kaplan–Meier curve the high-activity group declines faster, consistent with the unfavorable association (log-rank p = .001). LIHC ranks highest by sampling consensus for Retrograde trans-synaptic signaling by lipid.
This table summarizes Retrograde trans-synaptic signaling by lipid tumor–normal activity differences by data type. RNA-level activity shows significant tumor–normal differences in 10 cancer types, while mass-spec protein activity shows differences in 3. The strongest signals are in BLCA for RNA and LSCC for protein.
This table ranks reproducible tumor–normal activity differences for the pathway. A positive fold-change indicates higher activity in tumor tissue. The pathway shows higher tumor activity across COAD, BLCA and UCEC and lower tumor activity in KICH, BRCA and LUSC. In the COAD box plot, tumor samples show higher pathway activity than matched normal samples (log2 FC = +0.058, t-test p = .002).
This table shows molecular features associated with Retrograde trans-synaptic signaling by lipid pathway activity in patient tissues and cancer cell lines. In patient samples, pathway activity is most strongly linked to RNA and protein features, with the largest associated set in STAD. In cancer cell lines, RNA-expression features and functional dependencies dominate, with the largest set in BLOOD_Leukemia.
